Equity Research firms currently have a positive stance on shares of KemPharm, Inc. (NASDAQ:KMPH). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $10.50 on a short term basis.
At the time of writing, the stock was trading at $4.38. This represents a change from the opening price of -0.36%. In terms of performance, year to date, the stock is -78.05%. The monthly stock performance comes in at -10.10%. For the quarter, shares are performing at 1.63%. Weekly performance analysis shows the equity at -2.68%.
In taking a look at technical levels, shares are trading -3.64% away from the 50 day simple moving average and -56.65% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -79.42% away from it’s 52- week high and 24.55% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, KemPharm, Inc.’s RSI stands at 47.72. In looking at volatility levels, the shares saw weekly volatility of 5.26% and 6.75% over the past month.